Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer

Clinical trial NCT00003557 · COMPLETED

Trial details

NCT number: NCT00003557
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Extrahepatic Bile Duct Cancer Gallbladder Cancer Liver Cancer

Start date: 1999-01-01
Primary completion: 2000-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.